Trial Profile
Pharmacokinetics and tolerability of IV posaconazole administered peripherally in volunteers
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Chagas disease; Mycoses; Oropharyngeal candidiasis
- Focus Adverse reactions; Pharmacokinetics
- 17 Oct 2013 New trial record
- 13 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.